Contract Manufacturing, General

Jun 01, 2018
By BioPharm International Editors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
Jun 01, 2018
By BioPharm International Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
May 03, 2018
By BioPharm International Editors
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
Apr 01, 2018
BioPharm International
Developments and investments in single-use systems advance upstream biomanufacturing.
Apr 01, 2018
BioPharm International
Early adopters are benefiting from lower costs and increased productivity.
Mar 15, 2018
BioPharm International
Research suggests that working with a single contract partner can reduce development time and improve economics.
Mar 15, 2018
BioPharm International
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Mar 15, 2018
BioPharm International
A review of the latest investments in facilities, equipment, and acquisitions by biopharma contract service providers.
Feb 01, 2018
BioPharm International
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies.
native1_300x100
lorem ipsum